Neurofibromatosis 2

Keyphrases

• Neurofibromatosis Type 2 100%
• Merlin 30%
• Growth Rate 20%
• Meningioma 20%
• Clinical Research 20%
• Growth Regulation 20%
• Vestibular Schwannoma 20%
• Tumor 10%
• Mouse Model 10%
• Cell Activation 10%
• In Vitro Study 10%
• Aggressive Tumor 10%
• Disease Severity 10%
• Low Risk 10%
• Clinical Management 10%
• Hyperplasia 10%
• Radiation Therapy 10%
• Mortality Risk 10%
• Clinical Practice 10%
• Targeted Treatment 10%
• Surgical Risk 10%
• Cluster of Differentiation 44 (CD44) 10%
• Clinical Aspects 10%
• Schwannoma 10%
• Optimal Care 10%
• Schwannomin 10%
• Paxillin 10%
• Leptomeningeal 10%
• Young People 10%
• Multiple Patients 10%
• Treatment Facilities 10%
• Special Treatment 10%
• Molecular Research 10%
• Leptomeningeal Cells 10%

Medicine and Dentistry

• Neurofibromatosis Type II 100%
• Merlin 40%
• Neoplasm 20%
• Growth Regulation 20%
• Meningioma 20%
• Vestibular Schwannoma 20%
• Cell Activation 10%
• In Vitro 10%
• Clinical Feature 10%
• Disease Severity 10%
• Targeted Therapy 10%
• Clinical Research 10%
• Neurinoma 10%
• Clinical Management 10%
• Surgical Risk 10%
• Neurofibromatosis 10%
• Hyperplasia 10%
• Molecular Research 10%
• Paxillin 10%
• Radiation Therapy 10%